Diagnostic and prognostic value of autoantibodies for diabetes mellitus. A novel T1D autoimmunity target - zinc transporter 8 (ZnT8)

被引:0
|
作者
Shapovalyants, O. S. [1 ]
Nikonova, T. V. [1 ]
机构
[1] Endocrinol Res Ctr, Moscow, Russia
来源
DIABETES MELLITUS | 2011年 / 14卷 / 02期
关键词
type 1 mellitus diabetes; autoantibodies; immunnity; zinc transporter 8;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The progressive loss of beta cells in Type 1 Diabetes (T1D) is a result of chronic autoimmune attack targeted at diverse molecules expressing in the pancreatic beta cells. The appearance of cellular and humoral autoimmunity precedes the clinical manifestation of T1D. There are several autoantigens which are supposed to be involved in pathogenesis of TD1. Zinc transporter 8 (ZnT8; Slc30A8) was identified as a novel T1D autoimmunity target.
引用
收藏
页码:18 / 22
页数:5
相关论文
共 33 条
  • [21] Zinc transporter type 8 autoantibodies (ZnT8A): prevalence and phenotypic associations in latent autoimmune diabetes patients and patients with adult onset type 1 diabetes
    Andersen, Mette K.
    Harkonen, Taina
    Forsblom, Carol
    Groop, Per-Henrik
    Knip, Mikael
    Tuomi, Tiinamaija
    AUTOIMMUNITY, 2013, 46 (04) : 251 - 258
  • [22] Prevalence and diagnostic value of zinc transporter 8 antibodies in Bulgarian population with type 1 diabetes
    Chakarova, N.
    Grozeva, G.
    Dimova, R.
    Tankova, T.
    Atanassova, I.
    DIABETOLOGIA, 2017, 60 : S203 - S203
  • [23] The dynamic changes of zinc transporter 8 autoantibodies in Czech children from the onset of Type 1 diabetes mellitus
    Petruzelkova, L.
    Ananieva-Jordanova, R.
    Vcelakova, J.
    Vesely, Z.
    Stechova, K.
    Lebl, J.
    Dusatkova, P.
    Sumnik, Z.
    Coles, R.
    Powell, M.
    Furmaniak, J.
    Smith, B. Rees
    Kolouskova, S.
    DIABETIC MEDICINE, 2014, 31 (02) : 165 - 171
  • [24] Recognition of ZnT8, Proinsulin, and Homologous MAP Peptides in Sardinian Children at Risk of T1D Precedes Detection of Classical Islet Antibodies
    Niegowska, Magdalena
    Paccagnini, Daniela
    Mannu, Carla
    Targhetta, Clara
    Songini, Marco
    Sechi, Leonardo A.
    JOURNAL OF DIABETES RESEARCH, 2016, 2016
  • [25] Zinc Transporter 8 Autoantibodies (ZnT8A) and a Type 1 Diabetes Genetic Risk Score Can Exclude Individuals With Type 1 Diabetes From Inappropriate Genetic Testing for Monogenic Diabetes
    Patel, Kashyap A.
    Weedon, Michael N.
    Shields, Beverley M.
    Pearson, Ewan R.
    Hattersley, Andrew T.
    McDonald, Timothy J.
    DIABETES CARE, 2019, 42 (02) : E16 - E17
  • [26] Antibody profile of adult onset type 1 diabetes shows a high prevalence of Zinc Transporter 8 (ZnT8) and Insulinoma Antigen-2 (IA-2) antibodies
    Wyne, K.
    DIABETOLOGIA, 2019, 62 : S141 - S142
  • [27] Autoantibodies to zinc transporter 8 (ZnT8A) are more likely to persist after diagnosis in the presence of co-existing autoantibodies to glutamate decarboxylase (GADA) at Type 1 diabetes onset
    Williams, C. L.
    Gillespie, K. M.
    Williams, A. J. K.
    Long, A. E.
    DIABETIC MEDICINE, 2019, 36 : 61 - 61
  • [28] A low-volume rapid luciferase immunoprecipitation system (LIPS) assay utilising a novel antigen to detect autoantibodies to zinc transporter 8 (ZnT8A) in type 1 diabetes provides an alternative to conventional radioimmunoassay
    Williams, C. L.
    Gillespie, K. M.
    Lampasona, V.
    Williams, A. J. K.
    Long, A. E.
    DIABETIC MEDICINE, 2021, 38
  • [29] Zinc Transporter 8 and MAP3865c Homologous Epitopes are Recognized at T1D Onset in Sardinian Children
    Masala, Speranza
    Zedda, Maria Antonietta
    Cossu, Davide
    Ripoli, Carlo
    Palermo, Mario
    Sechi, Leonardo A.
    PLOS ONE, 2013, 8 (05):
  • [30] The prevalence and predictive value of the SLC30A8 R325W polymorphism and zinc transporter 8 autoantibodies in the development of GDM and postpartum type 1 diabetes
    Dereke, Jonatan
    Palmqvist, Sanna
    Nilsson, Charlotta
    Landin-Olsson, Mona
    Hillman, Magnus
    ENDOCRINE, 2016, 53 (03) : 740 - 746